In hematological malignancies, PD-1 expression has been reported increased in patients with Hodgkin’s lymphoma, diffuse large B-cell lymphoma and chronic lymphocytic leukemia [33–35]. This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.